Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian A Suarez

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Histopathology|September 5, 2024
Identifying mesonephric-like adenocarcinoma of the endometrium by combining SOX17 and PAX8 immunohistochemistryMaryam Tahir, Deyin Xing, Qingqing Ding, et al.
Cancer|September 17, 2014
Polymerase ɛ (POLE) mutations in endometrial cancer: clinical outcomes and implications for Lynch syndrome testingCaroline C Billingsley, David E Cohn, David G Mutch, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 20, 2015
Endometrial Cancer Insulin-Like Growth Factor 1 Receptor (IGF1R) Expression Increases with Body Mass Index and Is Associated with Pathologic Extent and PrognosisAmy S Joehlin-Price, Julie A Stephens, Jianying Zhang, et al.
American Journal of Obstetrics and Gynecology|August 17, 2025
My Two Cents on Two vs Four Mismatch Repair Protein Staining in Endometrial CancerDanielle C Glassman, Marie-Veronique Poirier, Sadie Longo, et al.
Gynecologic Oncology|January 22, 2014
Mismatch repair protein expression in 1049 endometrial carcinomas, associations with body mass index, and other clinicopathologic variablesAmy S Joehlin-Price, Carmen M Perrino, Julie Stephens, et al.
Gynecologic Oncology|June 25, 2019
Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739)Floor J Backes, David Cohen, Ritu Salani, et al.
Oncogene|April 12, 2018
Hypoxia-induced exosomes contribute to a more aggressive and chemoresistant ovarian cancer phenotype: a novel mechanism linking STAT3/Rab proteinsKalpana Deepa Priya Dorayappan, Ross Wanner, John J Wallbillich, et al.
Gynecologic Oncology|September 27, 2014
Comprehensive evaluation of caspase-14 in vulvar neoplasia: an opportunity for treatment with black raspberry extractAmy S Joehlin-Price, Camille T Elkins, Julie A Stephens, et al.
Gynecologic Oncology|March 10, 2016
Estrogen receptor-alpha as a predictive biomarker in endometrioid endometrial cancerFloor J Backes, Christopher J Walker, Paul J Goodfellow, et al.
Gynecologic Oncology|October 23, 2024
Cold ischemia time and formalin fixation time in endometrial cancer: Should breast cancer guidelines for preanalytical variables be applied to hysterectomy specimens?Paulina J Haight, Sydney Lammers, Quinn Kistenfeger, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Histopathology|September 5, 2024
Identifying mesonephric-like adenocarcinoma of the endometrium by combining SOX17 and PAX8 immunohistochemistryMaryam Tahir, Deyin Xing, Qingqing Ding, et al.
Cancer|September 17, 2014
Polymerase ɛ (POLE) mutations in endometrial cancer: clinical outcomes and implications for Lynch syndrome testingCaroline C Billingsley, David E Cohn, David G Mutch, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 20, 2015
Endometrial Cancer Insulin-Like Growth Factor 1 Receptor (IGF1R) Expression Increases with Body Mass Index and Is Associated with Pathologic Extent and PrognosisAmy S Joehlin-Price, Julie A Stephens, Jianying Zhang, et al.
American Journal of Obstetrics and Gynecology|August 17, 2025
My Two Cents on Two vs Four Mismatch Repair Protein Staining in Endometrial CancerDanielle C Glassman, Marie-Veronique Poirier, Sadie Longo, et al.
Gynecologic Oncology|January 22, 2014
Mismatch repair protein expression in 1049 endometrial carcinomas, associations with body mass index, and other clinicopathologic variablesAmy S Joehlin-Price, Carmen M Perrino, Julie Stephens, et al.
Gynecologic Oncology|June 25, 2019
Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739)Floor J Backes, David Cohen, Ritu Salani, et al.
Oncogene|April 12, 2018
Hypoxia-induced exosomes contribute to a more aggressive and chemoresistant ovarian cancer phenotype: a novel mechanism linking STAT3/Rab proteinsKalpana Deepa Priya Dorayappan, Ross Wanner, John J Wallbillich, et al.
Gynecologic Oncology|September 27, 2014
Comprehensive evaluation of caspase-14 in vulvar neoplasia: an opportunity for treatment with black raspberry extractAmy S Joehlin-Price, Camille T Elkins, Julie A Stephens, et al.
Gynecologic Oncology|March 10, 2016
Estrogen receptor-alpha as a predictive biomarker in endometrioid endometrial cancerFloor J Backes, Christopher J Walker, Paul J Goodfellow, et al.
Gynecologic Oncology|October 23, 2024
Cold ischemia time and formalin fixation time in endometrial cancer: Should breast cancer guidelines for preanalytical variables be applied to hysterectomy specimens?Paulina J Haight, Sydney Lammers, Quinn Kistenfeger, et al.
Pageof 5